A U.S. appeals court panel has refused to allow the Trump administration to proceed with a pilot initiative tied to a ...
The investigation focuses on allegations that UnitedHealth improperly limited hospitalizations among some people covered by ...
Startup Parabilis Medicines has raised $305 million in new funding, money that will help bring its lead drug for a variety of ...
Ocular Therapeutix is nearing the completion of a head-to-head clinical trial that could be key for the company, investors, ...
Digital health company Rune Labs, which helps people with Parkinson’s disease track their symptoms, said Thursday that it has appointed longtime Tempus executive Amy Gordon Franzen as CEO, and that ...
The guidelines, published Jan. 5 by the Health Resources and Services Administration, now recommend that average-risk women ...
RFK Jr.’s allies hope reducing the number of recommended pediatric vaccines opens the door to stripping vaccine makers of the ...
It’s the start of January. You’re just settling back into work after the holidays, maybe your kids just went back to school ...
If you’re a woman of a certain age, your social media feed may be filled with claims that a single therapy will fight ...
Biologically, how the GLP-1 is delivered into the body should make little difference: It’s the same peptide, just in a ...
Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.
Eli Lilly is in advanced talks to acquire Ventyx Biosciences, which is developing pills for autoimmune conditions, for more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results